[1]丁 晨,赵 鑫,王小雪,等.脑出血不同时机行微创血肿清除术对患者神经功能及氧化应激的影响[J].陕西医学杂志,2023,52(5):571-574,595.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.017]
　DING Chen,ZHAO Xin,WANG Xiaoxue,et al.Effects of minimally invasive hematoma removal at different times on neurological function and oxidative stress in patients with intracerebral hemorrhage[J].,2023,52(5):571-574,595.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.017]
点击复制

脑出血不同时机行微创血肿清除术对患者神经功能及氧化应激的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年5期
页码:
571-574,595
栏目:
临床研究
出版日期:
2023-05-05

文章信息/Info

Title:
Effects of minimally invasive hematoma removal at different times on neurological function and oxidative stress in patients with intracerebral hemorrhage
作者:
丁 晨; 赵 鑫; 王小雪; 梁馨之; 解 霞
(中国医科大学附属第一医院,辽宁 沈阳 110001)
Author(s):
DING Chen; ZHAO Xin; WANG Xiaoxue; LIANG Xinzhi; XIE Xia
(The First Affiliated Hospital of China Medical University,Shenyang 110001,China)
关键词:
脑出血;  微创血肿清除术;  氧化应激;  超早期;  血肿清除率;  神经功能
Keywords:
Intracerebral hemorrhage;  Minimally invasive hematoma removal;  Oxidative stress;  Ultra-early stage;  Hematoma clearance rate;  Neurological function
分类号:
R 743.34
DOI:
DOI:10.3969/j.issn.1000-7377.2023.05.017
文献标志码:
A
摘要:
目的:探究脑出血(ICH)在不同时机行微创血肿清除术对患者神经功能以及氧化应激的影响。方法:选取脑出血患者82例,采用随机数字表法分为观察组以及对照组,每组41例,对照组患者在早期(发病6～24 h内)实施微创血肿清除术,观察者患者在超早期(发病6 h内)实施微创血肿清除术,两组患者均持续随访观察6个月。比较两组术后6个月的临床疗效、治疗前后氧化应激指标[丙二醛(MDA)、超氧化物歧化酶(SOD)]、术后 24、72 h 血肿清除率、治疗前后的神经功能量表评分(NIHSS)和神经功能缺损评分(CSS)、治疗前后日常生活能力量表(ADL)评分,以及术后6个月内并发症发生情况。结果:术后6个月,观察组的治疗总有效率(97.56%)明显高于对照组(82.93%)(P<0.05)。两组MDA水平治疗后较治疗前均降低,治疗后的SOD水平较治疗前均上升(均P<0.05)。观察组治疗后的MDA水平较对照组下降明显,治疗后的SOD水平较对照组上升(均P<0.05)。两组NIHSS、CSS评分治疗后较治疗前均降低(均P<0.05)。观察组的NIHSS、CSS评分治疗后较对照组明显降低(均P<0.05)。两组ADL评分治疗后较治疗前均升高,观察组的ADL评分治疗后较对照组明显升高(均P<0.05)。术后6个月,观察组(4.88%,2例/41例)较对照组(19.51%,8例/41例)的并发症发生率明显下降低,两组对比差异有统计学意义(P<0.05)。结论:ICH患者,在超早期(发病6 h内)实施微创血肿清除术与早期实施手术相比,能够降低患者的氧化应激反应,改善神经功能,且安全性良好。
Abstract:
Objective:To explore the effects of minimally invasive hematoma removal at different times on neurological function and oxidative stress in patients with intracerebral hemorrhage(ICH).Methods:A total of 82 ICH patients were randomly divided into observation group and control group,with 41 cases in each group.The control group was treated with minimally invasive hematoma removal in the early stage(6 to 24 hours after onset),and the observation group was treated with minimally invasive hematoma removal in the ultra-early stage(within 6 hours after onset).The patients in both groups were followed up for 6 months.The clinical efficacy,oxidative stress indexes [malondialdehyde(MDA),superoxide dismutase(SOD)]before and after treatment,The hematoma clearance rate at 24 hours and 72 hours after operation,scores of NIHSS,CSS and ADL before and after treatment,complications within 6 months after operation were compared.Results:Six months after operation,the total effective rate of treatment in the observation group(97.56%)was significantly higher than that(82.93%)in the control group(P<0.05).After treatment,the MDA level of the two groups was lower than that before treatment,and the SOD level after treatment was higher than that before treatment(all P<0.05).After treatment,the MDA level in the observation group was significantly lower than that in the control group,and the SOD level after treatment was higher than that in the control group(all P<0.05).The NIHSS and CSS scores of the two groups after treatment were lower than those before treatment(all P<0.05).The NIHSS and CSS scores of the observation group were significantly lower than those of the control group after treatment(all P<0.05).The ADL score of the two groups after treatment was lower than that before treatment,and the ADL score of the observation group after treatment was significantly lower than that of the control group(all P<0.05).Six months after operation,the incidence of complications in the observation group(4.88%,2 cases /41 cases)was significantly lower than that in the control group(19.51%,8 cases /41 cases),the difference was statistically significant(P<0.05).Conclusion:For ICH patients,compared with early surgery,minimally invasive hematoma removal at ultra-early stage(within 6 hours after onset)can reduce the oxidative stress response of patients and improve neurological function,with good safety.

参考文献/References:

[1] 李延喜,郭世文.微创手术对高血压基底节脑出血患者生活质量及脑功能恢复效果的影响研究[J].陕西医学杂志,2020,49(2):166-168,172.
[2] Kim HR,Han JY,Park YH,et al.Supernumerary phantom limb in a patient with basal ganglia hemorrhage:A case report and review of the literature[J].BMC Neurology,2017,17(1):180-182.
[3] 王 莉,王 磊.安宫牛黄丸联合依达拉奉对高血压脑出血病人氧化应激的影响[J].中西医结合心脑血管病杂志,2020,18(18):3105-3108.
[4] 姜 飞,王东玉.依达拉奉右莰醇联合尿激酶静脉溶栓治疗急性脑梗死合并糖尿病对患者血清氧化应激水平、颈总动脉内-中膜厚度、血清基质金属蛋白酶-12水平的影响[J].陕西医学杂志,2022,51(1):88-91.
[5] 朱文锐.微创颅内血肿清除术治疗高血压性基底节区脑出血的临床疗效分析[J].世界中医药,2017,12(1):451.
[6] 杨生琴.立体定向软通道颅内血肿清除术治疗高血压性脑出血患者近期神经功能恢复临床研究[J].陕西医学杂志,2019,48(4):482-484.
[7] 刘金辉,王忠安,龚光辉,等.超早期与早期微创手术治疗中等量基底节区高血压性脑出血的疗效比较[J].中国微创外科杂志,2021,21(2):117-120.
[8] 迟大鹏,姜晓东,郎铁成,等.超早期小骨窗微创脑出血清除术联合中医理疗对老年高血压脑出血患者神经功能和生活质量的影响[J].现代中西医结合杂志,2017,26(10):1040-1042.
[9] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2019)[J].中华神经科杂志,2019,52(12):994-1005.
[10] 解益宁,姜素兰,张晶晶.介入溶栓联合高压氧对急性闭塞性脑梗死患者NHISS评分和生活质量的影响[J].中风与神经疾病杂志,2022,39(11):982-985.
[11] 吴培培,董少军,孙田田,等.丁苯酞联合阿司匹林和硫酸氢氯吡格雷对急性脑梗死患者NIHSS评分和mRS评分影响[J].河北医学,2022,28(2):327-331.
[12] 卓健伟,杨理坤,朱 洁,等.阿托伐他汀对慢性硬膜下血肿患者术后MBI、CSS评分的影响[J].现代生物医学进展,2020,20(18):3582-3586.
[13] 李雪娜,海 英.清脑益元汤对缺血性中风患者的疗效及Barthel指数、ADL评分的变化研究[J].中医药学报,2020,48(9):46-49.
[14] 叶 妮,王 钢,温大平,等.早期中医康复介入对脑出血患者功能及生活能力恢复的影响[J].陕西中医,2020,41(9):1205-1207.
[15] 赵 亮.滋阴化瘀通窍汤对高血压脑出血患者术后神经功能改善及预后研究[J].陕西中医,2018,39(8):1126-1128.
[16] 蔡 宾,张 梅,彭 琳,等.青年及中老年脑出血血肿扩大相关危险因素研究[J].中国脑血管病杂志,2019,16(10):520-525.
[17] 宋永福,何升学,赵金兵,等.高血压性基底节区脑出血患者血清s100钙结合蛋白B、神经特异性烯醇化酶水平对病情的评估及预后的预测价值[J].临床神经病学杂志,2020,33(1):17-22.
[18] 邱方方,陆远强.影响动脉瘤性蛛网膜下腔出血的预后因素分析[J].中华急诊医学杂志,2019,28(3):379-383.
[19] Bin L,Shaopeng L,Huihui C,et al.Clinical eflects of minimallyin vasive hem atomaremoval for hypertensive intracerebralhemorrhage at different operalion time[J].Clinical Medicine,2018,48(4):298-301.
[20] 董晓风.超早期小骨窗微创手术治疗高血压脑出血患者的价值研究[J].中国药物与临床,2019,19(12):2071-2072.
[21] 柯国秀,王国军,王建生,等.早期继续出血的自发性脑出血患者不同时间点氧化应激及炎性介质水平的变化[J].卒中与神经疾病,2017,24(4):306-309.
[22] 高 震,陈梦燚,姚庆龄,等.脑血疏口服液对急性脑出血病人血清氧化应激指标的影响[J].中西医结合心脑血管病杂志,2018,16(14):124-125.
[23] 刘 青,叶 鹏,Divani AA,等.血压变异性预测自发性脑出血患者的院内不良预后[J].中华高血压杂志,2019,27(8):707-709.

相似文献/References:

[1]杨瑞林,李博.微创穿刺血肿清除术治疗高血压脑出血65例[J].陕西医学杂志,2016,(10):1371.
[2]杨生琴.立体定向软通道颅内血肿清除术治疗高血压性脑出血患者近期神经功能恢复临床研究[J].陕西医学杂志,2019,(4):482.
　YANG Shengqin..Clinical research of neurological function in patients with hypertensive intracerebral hemorrhage by stereotactic soft channel intracranial hematoma evacuation[J].,2019,(5):482.
[3]赵志靖,第五飞虎△,邓毅恒,等.醒脑静对大鼠脑出血病灶周围星形胶质细胞表达水通道蛋白4的影响研究*[J].陕西医学杂志,2019,(10):1251.
　ZHAO Zhijing,DIWU Feihu,DENG Yiheng,et al.Effect of Xingnaojing on the expression of AQP4 in 〖JZ〗peripheral astrocytes of rats after intracerebral hemorrhage[J].,2019,(5):1251.
[4]段 鹏,杨明金△.脑出血患者神经元特异性烯醇化酶检测及临床意义[J].陕西医学杂志,2020,49(2):234.
　DUAN Peng,YANG Mingjin..Detection and clinical significance of neuron specific enolase in patients with cerebral hemorrhage[J].,2020,49(5):234.
[5]黄亮星,贺东红△.脑出血患者神经内分泌因子表达水平与脑出血量及认知功能相关性研究*[J].陕西医学杂志,2020,49(4):439.
　HUANG Liangxing,HE Donghong..Correlation between expression levels of neuroendocrine factors and the amount of hemorrhage and cognitive function in patients with cerebral hemorrhage[J].,2020,49(5):439.
[6]栾百婷,罗 涛,程洪瑜,等.脑出血患者穿刺引流术后尿激酶应用剂量和时间研究*[J].陕西医学杂志,2020,49(11):1399.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.008]
　LUAN Baiting,LUO Tao,CHENG Hongyu,et al.Study on the dose and timing of the application of urokinase after puncture drainage in patients with intracerebral hemorrhage[J].,2020,49(5):1399.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.008]
[7]李晨红,黄传俊,姜晨黎,等.甘露醇联合肠内营养治疗脑出血疗效及对患者免疫功能的影响[J].陕西医学杂志,2021,50(2):212.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.022]
　LI Chenhong,HUANG Chuanjun,JIANG Chenli,et al.Efficacy of mannitol combined with enteral nutrition in treatment of cerebral hemorrhage and its influence on patients' immune function[J].,2021,50(5):212.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.022]
[8]李宝福,刘柏麟,袁 兴,等.辅酶Q10对小鼠脑出血后神经保护作用的实验研究[J].陕西医学杂志,2022,51(11):1337.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.004]
　LI Baofu,LIU Bolin,YUAN Xing,et al.Neuroprotective effect of coenzyme Q10 on intracerebral hemorrhage in mice[J].,2022,51(5):1337.[doi:DOI:10.3969/j.issn.1000-7377.2022.11.004]
[9]张百平,孙树凯,于庆伟,等.谷氨酰胺对脑出血小鼠神经保护和抗炎作用实验研究[J].陕西医学杂志,2023,52(2):128.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.002]
　ZHANG Baiping,SUN Shukai,YU Qingwei,et al.Neuroprotective and anti-inflammatory effects of glutamine in mice with intracerebral hemorrhage[J].,2023,52(5):128.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.002]
[10]李 民,曹 杰,刘晓斌,等.老年高血压脑出血并发卒中相关性肺炎早期患者血清感染指标的检测及临床意义[J].陕西医学杂志,2023,52(10):1419.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.031]

备注/Memo

备注/Memo:
基金项目:辽宁省教育厅科学研究经费资助项目(FWZR2020004)
更新日期/Last Update: 2023-05-05